Insider Trading & Ownership - Behbahani Ali

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Behbahani Ali
Goto 0, 1, 2, Next
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-09-16
Purchase
2024-09-17
8:24 pm
MBX Biosciences Inc.MBXBehbahani Ali
10% Owner
500,000$16$8,000,0003,614,486
(Indirect)
View
2023-07-17
Purchase
2023-07-19
7:06 pm
Savara IncSVRABehbahani Ali
10% Owner
333,333$3$999,99924,471,264
(Indirect)
View
2023-07-05
Purchase
2023-07-06
4:45 pm
Black Diamond Therapeutics Inc.BDTXBehbahani Ali
Director
1,000,000$5$5,000,0004,489,527
(Indirect
Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-09-20
Option Award
2024-09-20
4:30 pm
N/A
N/A
Black Diamond Therapeutics Inc.BDTXBehbahani Ali
Director
3,007$4.784,506,341
(Direct)
View
2024-09-16
Conversion
2024-09-17
8:24 pm
N/A
N/A
MBX Biosciences Inc.MBXBehbahani Ali
10% Owner
40,557,180$03,614,486
(Indirect)
View

Ownership
2024-09-12
7:24 pm
N/A
N/A
MBX Biosciences Inc.MBXBehbahani Ali
10% Owner
0$03,114,486
(Indirect)
View
2024-07-01
Option Award
2024-07-01
5:10 pm
2025-07-01
2034-07-01
Adaptimmune Therapeutics PLCADAPBehbahani Ali
Director
1,144,686$01,144,686
(Direct)
View
2024-06-21
Option Award
2024-06-21
4:25 pm
N/A
N/A
Black Diamond Therapeutics Inc.BDTXBehbahani Ali
Director
2,887$4.984,503,334
(Direct)
View
2024-06-13
Option Award
2024-06-14
4:30 pm
N/A
2034-06-12
Nkarta Inc.NKTXBehbahani Ali
Director
22,500$022,500
(Direct)
View
2024-06-12
Option Award
2024-06-13
8:12 pm
N/A
2034-06-12
Monte Rosa Therapeutics Inc.GLUEBehbahani Ali
Director
10% Owner
22,100$022,100
(Direct)
View
2024-06-11
Option Award
2024-06-12
5:30 pm
N/A
2034-06-10
Korro Bio Inc.KRROBehbahani Ali
Director
10% Owner
5,190$05,190
(Direct)
View
2024-06-04
Option Award(A)
2024-06-07
5:25 pm
N/A
2034-06-04
CVRx Inc.CVRXBehbahani Ali
Director
27,250$027,250
(Direct)
View
2024-06-04
Option Award
2024-06-06
8:35 pm
N/A
2034-06-04
CVRx Inc.CVRXBehbahani Ali
Director
20,961$020,961
(Direct)
View
2024-06-06
Option Award
2024-06-06
6:20 pm
N/A
2034-06-05
Black Diamond Therapeutics Inc.BDTXBehbahani Ali
Director
30,550$030,550
(Direct)
View
2024-05-28
Option Award
2024-06-06
5:28 pm
N/A
2034-05-28
Arcellx Inc.ACLXBehbahani Ali
Director
8,011$08,011
(Direct)
View
2024-05-30
Option Award
2024-05-31
4:50 pm
N/A
2034-05-30
CRISPR Therapeutics AGCRSPBehbahani Ali
Director
13,000$013,000
(Direct)
View
2024-04-22
Option Award
2024-04-24
5:00 pm
N/A
N/A
Korro Bio Inc.KRROBehbahani Ali
Director
10% Owner
17,857$561,090,793
(Indirect)
View
2024-03-15
Option Award
2024-04-03
9:00 pm
N/A
N/A
Black Diamond Therapeutics Inc.BDTXBehbahani Ali
Director
3,166$4.544,500,447
(Direct)
View
2024-01-15
Option Award
2024-01-17
5:06 pm
2025-01-15
2034-01-15
Adaptimmune Therapeutics PLCADAPBehbahani Ali
Director
40,950$040,950
(Direct)
View
2023-12-14
Exercise
2023-12-18
4:40 pm
N/A
2023-12-14
CVRx Inc.CVRXBehbahani Ali
Director
316$0316
(Direct)
View
2023-12-14
Exercise
2023-12-18
4:40 pm
N/A
N/A
CVRx Inc.CVRXBehbahani Ali
Director
316$0.237316
(Direct)
View
2023-12-15
Option Award
2023-12-15
4:48 pm
N/A
N/A
Black Diamond Therapeutics Inc.BDTXBehbahani Ali
Director
4,455$2.734,497,281
(Direct)
View
2023-11-03
Option Award
2023-11-07
9:15 pm
N/A
2033-11-02
Korro Bio Inc.KRROBehbahani Ali
Director
10% Owner
1,088,936$01,088,936
(Direct)
View
2023-09-15
Option Award
2023-09-18
5:34 pm
N/A
N/A
Black Diamond Therapeutics Inc.BDTXBehbahani Ali
Director
3,299$3.64,492,826
(Direct)
View
2023-07-03
Option Award
2023-07-03
5:16 pm
2024-07-03
2033-07-03
Adaptimmune Therapeutics PLCADAPBehbahani Ali
Director
933,317$0933,317
(Direct)
View
2023-06-16
Option Award
2023-06-16
6:42 pm
N/A
N/A
Black Diamond Therapeutics Inc.BDTXBehbahani Ali
Director
5,655$2.13,489,527
(Direct)
View
2023-06-14
Option Award
2023-06-16
4:57 pm
N/A
2033-06-14
Arcellx Inc.ACLXBehbahani Ali
Director
11,459$011,459
(Direct)
View
2023-06-14
Option Award
2023-06-15
4:42 pm
N/A
2033-06-13
Monte Rosa Therapeutics Inc.GLUEBehbahani Ali
Director
10% Owner
20,500$020,500
(Direct)
View
2023-06-13
Other
2023-06-15
4:28 pm
N/A
N/A
Mirum Pharmaceuticals Inc.MIRMBehbahani Ali
10% Owner
2,030,135$02,060,270
(Indirect)
View
2023-06-08
Option Award
2023-06-09
5:48 pm
N/A
2033-06-08
CRISPR Therapeutics AGCRSPBehbahani Ali
Director
13,000$013,000
(Direct)
View
2023-06-07
Option Award
2023-06-09
4:50 pm
N/A
2033-06-06
Nkarta Inc.NKTKBehbahani Ali
Director
22,500$022,500
(Direct)
View
2023-06-05
Option Award
2023-06-07
6:54 pm
N/A
2033-06-04
CVRx Inc.CVRXBehbahani Ali
Director
12,012$012,012
(Direct)
View
2023-06-01
Other
2023-06-05
4:46 pm
N/A
N/A
Arcellx Inc.ACLXBehbahani Ali
Director
141$0565
(Direct)
View
2023-05-16
Option Award
2023-05-17
9:16 pm
N/A
2033-05-15
Black Diamond Therapeutics Inc.BDTXBehbahani Ali
Director
16,500$016,500
(Direct)
View
2023-03-16
Option Award
2023-03-20
4:41 pm
N/A
N/A
Black Diamond Therapeutics Inc.BDTXBehbahani Ali
Director
7,111$1.673,483,872
(Direct)
View
(A) Indicate amendment filing.
Goto 0, 1, 2, Next